abstract |
The present invention inhibits TLR9, which is one of receptors that recognize extracellular DNA, and has excellent preventive and therapeutic effects on autoimmune disease, inflammation, allergy, asthma, graft rejection or graft-versus-host disease. Provide drugs. The following general formula (1): Or a salt thereof, or a solvate thereof. [Selection figure] None |